CIRC Biosciences, Inc. — Form D
CIRC Biosciences, Inc. of CHICAGO, IL, a company, filed a Form D exempt-offering notice with the SEC on 2024-05-01. The offering totals $7.0M, of which $7.0M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2024-05-01
- Form: D
- Accession: 0001834514-24-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $7.0M
- Amount sold: $7.0M
- Investors: 19
- Date of first sale: 2024-04-15
- Security types: debt
- Revenue range: Decline to Disclose
- SEC file number: 021-512128
Issuer
- Name: CIRC Biosciences, Inc.
- CIK: 0001834514
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2019
- Address: 400 N. ABERDEEN, SUITE 900, CHICAGO, IL, 60642
- Phone: 3128471322
Officers, directors & promoters (14)
| Name | Role | Location |
|---|
| Jeffrey S Aronin | Director | Chicago, IL |
| Sai J Chavala | Director | Dallas, TX |
| Timothy M Cunniff | Director | Chicago, IL |
| Antonio J Gracias | Director | Chicago, IL |
| Patrick J Morris | Director | Chicago, IL |
| Patrick J Morris | Executive Officer | Chicago, IL |
| Darien J Parhad | Executive Officer | Chicago, IL |
| ANTONIO GRACIAS | Director | Hawthorne, CA |
| Jeffrey Aronin | Director | Exton, PA |
| Patrick Morris | Director | Chicago, IL |
| Patrick Morris | Executive Officer | Chicago, IL |
| Darien Parhad | Executive Officer | Exton, PA |
| Timothy Cunniff | Director | Chicago, IL |
| Sai Chavala | Director | Dallas, TX |
Other filings by this issuer (2)
More